These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 12352009)

  • 1. Arterial retention of apolipoprotein B(48)- and B(100)-containing lipoproteins in atherogenesis.
    Proctor SD; Vine DF; Mamo JC
    Curr Opin Lipidol; 2002 Oct; 13(5):461-70. PubMed ID: 12352009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The central role of arterial retention of cholesterol-rich apolipoprotein-B-containing lipoproteins in the pathogenesis of atherosclerosis: a triumph of simplicity.
    Borén J; Williams KJ
    Curr Opin Lipidol; 2016 Oct; 27(5):473-83. PubMed ID: 27472409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subendothelial retention of atherogenic lipoproteins in early atherosclerosis.
    Skålén K; Gustafsson M; Rydberg EK; Hultén LM; Wiklund O; Innerarity TL; Borén J
    Nature; 2002 Jun; 417(6890):750-4. PubMed ID: 12066187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of lipoprotein retention by the extracellular matrix.
    Gustafsson M; Borén J
    Curr Opin Lipidol; 2004 Oct; 15(5):505-14. PubMed ID: 15361785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Defining the atherogenicity of large and small lipoproteins containing apolipoprotein B100.
    Véniant MM; Sullivan MA; Kim SK; Ambroziak P; Chu A; Wilson MD; Hellerstein MK; Rudel LL; Walzem RL; Young SG
    J Clin Invest; 2000 Dec; 106(12):1501-10. PubMed ID: 11120757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of extracellular retention of low density lipoproteins in atherosclerosis.
    Borén J; Gustafsson M; Skålén K; Flood C; Innerarity TL
    Curr Opin Lipidol; 2000 Oct; 11(5):451-6. PubMed ID: 11048887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolism and Modification of Apolipoprotein B-Containing Lipoproteins Involved in Dyslipidemia and Atherosclerosis.
    Morita SY
    Biol Pharm Bull; 2016; 39(1):1-24. PubMed ID: 26725424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The response-to-retention hypothesis of atherogenesis reinforced.
    Williams KJ; Tabas I
    Curr Opin Lipidol; 1998 Oct; 9(5):471-4. PubMed ID: 9812202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of the proteoglycan binding site in apolipoprotein B48.
    Flood C; Gustafsson M; Richardson PE; Harvey SC; Segrest JP; Borén J
    J Biol Chem; 2002 Aug; 277(35):32228-33. PubMed ID: 12070165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum amyloid A and lipoprotein retention in murine models of atherosclerosis.
    O'Brien KD; McDonald TO; Kunjathoor V; Eng K; Knopp EA; Lewis K; Lopez R; Kirk EA; Chait A; Wight TN; deBeer FC; LeBoeuf RC
    Arterioscler Thromb Vasc Biol; 2005 Apr; 25(4):785-90. PubMed ID: 15692094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intimal retention of cholesterol derived from apolipoprotein B100- and apolipoprotein B48-containing lipoproteins in carotid arteries of Watanabe heritable hyperlipidemic rabbits.
    Proctor SD; Mamo JC
    Arterioscler Thromb Vasc Biol; 2003 Sep; 23(9):1595-600. PubMed ID: 12842838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progression of renal failure: role of apolipoprotein B-containing lipoproteins.
    Attman PO; Samuelsson O; Alaupovic P
    Kidney Int Suppl; 1997 Dec; 63():S98-101. PubMed ID: 9407433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apolipoprotein B-100 kinetics and static plasma indices of triglyceride-rich lipoprotein metabolism in overweight men.
    Chan DC; Watts GF; Ng TW; Uchida Y; Sakai N; Yamashita S; Barrett PH
    Clin Biochem; 2005 Sep; 38(9):806-12. PubMed ID: 15992790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipoprotein lipase bound to apolipoprotein B lipoproteins accelerates clearance of postprandial lipoproteins in humans.
    Zheng C; Murdoch SJ; Brunzell JD; Sacks FM
    Arterioscler Thromb Vasc Biol; 2006 Apr; 26(4):891-6. PubMed ID: 16410459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of lipoproteins of intestinal origin in human atherosclerotic plaque.
    Pal S; Semorine K; Watts GF; Mamo J
    Clin Chem Lab Med; 2003 Jun; 41(6):792-5. PubMed ID: 12880143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipoprotein receptors and atherosclerosis.
    Kostner GM
    Biochem Soc Trans; 1989 Aug; 17(4):639-41. PubMed ID: 2548904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apolipoprotein B: a clinically important apolipoprotein which assembles atherogenic lipoproteins and promotes the development of atherosclerosis.
    Olofsson SO; Borèn J
    J Intern Med; 2005 Nov; 258(5):395-410. PubMed ID: 16238675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of native apolipoprotein B-containing lipoproteins in atherosclerosis: cellular mechanisms.
    Sehayek E; Eisenberg S
    Curr Opin Lipidol; 1994 Oct; 5(5):350-3. PubMed ID: 7858909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subendothelial lipoprotein retention as the initiating process in atherosclerosis: update and therapeutic implications.
    Tabas I; Williams KJ; Borén J
    Circulation; 2007 Oct; 116(16):1832-44. PubMed ID: 17938300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retention of fluorescent-labelled chylomicron remnants within the intima of the arterial wall--evidence that plaque cholesterol may be derived from post-prandial lipoproteins.
    Proctor SD; Mamo JC
    Eur J Clin Invest; 1998 Jun; 28(6):497-503. PubMed ID: 9693943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.